RUA Life Sciences plc (LON:RUA – Get Free Report) shares rose 10.5% during trading on Monday . The company traded as high as GBX 29.90 and last traded at GBX 28.75. 291,273 shares were traded during mid-day trading, an increase of 29% from the average daily volume of 225,573 shares. The stock had previously closed at GBX 26.03.
RUA Life Sciences Price Performance
The company has a quick ratio of 7.32, a current ratio of 4.64 and a debt-to-equity ratio of 18.95. The stock has a market cap of £17.84 million, a P/E ratio of -2.61 and a beta of 0.95. The firm has a 50 day moving average price of GBX 22.71 and a 200 day moving average price of GBX 18.67.
RUA Life Sciences (LON:RUA – Get Free Report) last announced its quarterly earnings data on Tuesday, June 30th. The company reported GBX (0.33) earnings per share (EPS) for the quarter. RUA Life Sciences had a negative net margin of 3.26% and a negative return on equity of 2.03%.
RUA Life Sciences Company Profile
The RUA Life Sciences group was created in April 2020 when AorTech International plc acquired RUA Medical Devices Ltd to create a fully formed medical device business. RUA Life Sciences is the holding company of the group trading through four businesses all exploiting the group’s polymer technology. Our vision is to improve the lives of millions of patients by improving and enabling medical devices with Elast-EonTM, the worlds leading long term implantable polyurethane.
Featured Stories
- Five stocks we like better than RUA Life Sciences
- Snowflake Could Be Headed for New Highs Despite Insider Selling
- MongoDB Is Surging—And the Next Catalyst Is Almost Here
- If Boeing Ramps Up Production, These Suppliers May Win Big
- Marvell Takes a Shot a Broadcom’s Throne With Google Deal
Receive News & Ratings for RUA Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RUA Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
